Earnings Releases·Oct 29, 2026, 4:21 PM ET

Alphatec Holdings, Inc. — Third Quarter 2026 Earnings Summary

Total revenue reached $221 million, a 13% year-over-year increase driven by 14% growth in surgical revenue, though GAAP net loss of $5 million contrasted with $15 million Non-GAAP net income.
Full-year 2026 guidance was reaffirmed at approximately $862 million in total revenue and $137 million in adjusted EBITDA, reflecting 13% total revenue growth and continued profitability expansion.
Management identified lower biologics attachment as the primary cause for the quarter missing expectations, citing this as a key priority to address while maintaining confidence in the procedure-focused strategy.
Operational highlights included a 20% year-over-year increase in case volumes, a 25% rise in net new surgeon users, and the appointment of Tommy Carls as Executive Vice President of Data Intelligence & Strategy.